Skip to main content

Advertisement

Log in

Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system

  • Original Article
  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

The present study aimed to develop matrix-type transdermal drug delivery system (TDDS) of metoprolol tartrate using polyvinyl pyrrolidone (PVP) and polyvinyl alcohol (PVA). The transdermal films were evaluated for physical parameters, Fourier transform infrared spectroscopy analysis (FTIR), differential scanning calorimetry (DSC), in vitro drug release, in vitro skin permeability, skin irritation test and stability studies. The films were found to be tough, non-sticky, easily moldable and possess good tensile strength. As the concentration of PVA was increased, the tensile strength of the films was also increased. Results of FTIR spectroscopy and DSC revealed the absence of any drug-polymer interactions. In vitro release of metoprolol followed zero-order kinetics and the mechanism of release was found to be diffusion rate controlled. In vitro release studies of metoprolol using Keshary-Chein (vertical diffusion cell) indicated 65.5 % drug was released in 24 h. In vitro skin permeation of metoprolol transdermal films showed 58.13 % of the drug was released after 24 h. In vitro skin permeation of metoprolol followed zero-order kinetics in selected formulations. The mechanism of release was found to be diffusion rate controlled. In a 22-day skin irritation test, tested formulation of transdermal films did not exhibit any allergic reactions, inflammation, or contact dermatitis. The transdermal films showed good stability in the 180-day stability study. It can be concluded that the TDDS of MPT can help in bypassing the first-pass effect and will provide patient improved compliance, without sacrificing the therapeutic advantages of the drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Sareen R, Jain N, Kumar D. An insight to osmotic drug delivery. Curr Drug Deliv. 2012;9(3):285–96.

    Article  CAS  PubMed  Google Scholar 

  2. Awasthi R, Kulkarni GT. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Drug Deliv. 2016;23(2):378–94.

    Article  CAS  PubMed  Google Scholar 

  3. Jain NK. Advances in controlled and novel drug delivery. 1st ed: CBS Publishers and Distributors; 2001. p. 426–36.

  4. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Akhtar N, Raish M, Aqil M. Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharm J. 2015;23(6):587–602.

    Article  PubMed  Google Scholar 

  6. Nguyen KT, Ita KB, Parikh SJ, Popova IE, Bair DA. Transdermal delivery of captopril and metoprolol tartrate with microneedles. Drug Delivery Letters. 2014;4(3):236–43.

    Article  CAS  Google Scholar 

  7. Bhatt DC, Dhake AS, Khar RK, Mishra DN. Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate. Yakugaku Zasshi. 2008;128(9):1325–31.

    Article  CAS  PubMed  Google Scholar 

  8. Aqil M, Sultana Y, Ali A, Dubey K, Najmi AK, Pillai KK. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization. Drug Deliv. 2004;11(1):27–31.

    Article  CAS  PubMed  Google Scholar 

  9. Aqil M, Ali A, Sultana Y, Saha N. Comparative bioavailability of metoprolol tartrate after oral and transdermal administration in healthy male volunteers. Clinical Drug Investigation. 2007;27(12):833–9.

    Article  CAS  PubMed  Google Scholar 

  10. Aqil M, Sultana Y, Ali A. Matrix type transdermal drug delivery systems of metoprolol tartrate: In vitro characterization. Acta Pharma. 2003;53:119–25.

    CAS  Google Scholar 

  11. Sankar V, Johnson DB, Sivanand V, Ravichandran V, Raghuram S. Design and evaluation of nifedipine transdermal films. Indian J Pharm Sci. 2003;65:510–5.

    CAS  Google Scholar 

  12. Shinde AJ, Shinde AL, More HN. Design and evaluation of transdermal drug delivery system of gliclazide. Asian J Pharm. 2010;4:121–9.

    Article  CAS  Google Scholar 

  13. Manvi FV, Dandagi PM, Gadad AP, Mastiholimath VS, Jagadesh T. Formulation of a transdermal drug delivery system of ketotifen fumarate. Indian J Pharm Sci. 2003;65:239–43.

    CAS  Google Scholar 

  14. Lec ST, Yac SH, Kim SW, Berner B. One way membrane for transdermal drug delivery system. II. System optimization. Int J Pharm. 1991;77(2–3):231–7.

    Google Scholar 

  15. Lewis S, Pandey S, Udupa N. Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation. Indian J Pharm Sci. 2006;68:179–84.

    Article  CAS  Google Scholar 

  16. Satheeshababu BK, Shivakumar KL. Synthesis of conjugated chitosan and its effect on drug permeation from transdermal films. Indian J Pharm Sci. 2013;75(2):162–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Dua K, Pabreja K, Ramana MV. Aceclofenac topical dosage forms: in vitro and in vivo characterization. Acta Pharma. 2010;60:467–78.

    Article  CAS  Google Scholar 

  18. Gungor S, Bektas A, Alp FI, Uydes-Dogan BS, Ozdemir O, Araman A, et al. Matrix-type transdermal films of verapamil hydrochloride: in vitro permeation studies through excised rat skin and pharmacodynamic evaluation in rats. Pharm Dev Technol. 2008;13(4):283–9.

  19. Dua K, Chakravarthi S, Kumar D, Sheshala R, Gupta G. Formulation, characterization, in vitro, in vivo, and histopathological evaluation of transdermal drug delivery containing norfloxacin and Curcuma longa. International Journal of Pharmaceutical Investigation. 2013;3:183–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dua K, Ramana MV, Madan J, Gupta G, Chakravarthi S, Awasthi R, et al. Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds. Interventional Medicine and Applied Science. 2016;8(2):68–76.

  21. Jibry N, Murdan S. In vivo investigation, in mice and in man, in to the irritation potential of novel amphiphilogels being studied as transdermal drug carriers. Eur J Pharm Biopharm. 2004;58:107–19.

    Article  CAS  PubMed  Google Scholar 

  22. Aqil M, Zafar S, Ali A, Ahmad S. Transdermal drug delivery of labetolol hydrochloride: system development, in vitro, ex vivo and in vivo characterization. Curr Drug Deliv. 2005;2:125–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Venkata Ramana Malipeddi.

Ethics declarations

Conflict of interest

The authors confirm that this article has no conflict of interest.

Declaration of animal studies

The animal experimental protocol was approved by the Institutional Animal Ethical Committee. The animals were handled as per the guidelines of the Committee for the Purpose of Control and Supervision on Experimental animals (CPCSEA), New Delhi, India.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malipeddi, V.R., Awasthi, R., Ghisleni, D.D.M. et al. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system. Drug Deliv. and Transl. Res. 7, 66–76 (2017). https://doi.org/10.1007/s13346-016-0334-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-016-0334-7

Keywords

Navigation